Extremely high-risk patients with acute coronary syndrome: How "extreme" should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?
作者信息
Rallidis Loukianos S, Tsamoulis Donatos, Leventis Ioannis, Kalogeras Petros, Delakis Iosif, Samiotis Elefterios, Kalantzis Charalampos, Malkots Belkis, Tasoulas Dimitrios, Bouratzis Vasileios, Eleutheriou Dimitris, Daios Stylianos, Potoupni Victoria, Zervakis Stelios, Xygka Georgia, Miliotou Argyro, Papathanasiou Konstantinos A, Vlachopoulos Charalambos
机构信息
2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, University General Hospital ATTIKON, Athens, Greece.
Department of Cardiology, Thriasio General Hospital, Elefsina, Greece.
出版信息
Kardiol Pol. 2023;81(10):1012-1014. doi: 10.33963/KP.a2023.0147. Epub 2023 Jul 4.
PMID:37401581
Abstract
摘要
Zotero 插件